|
|
protein polyubiquitination
|
GO:0000209 |
110 |
1.000
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
1.000
|
Human |
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
1.000
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
1.000
|
Human |
|
|
protein k48 linked ubiquitination
|
GO:0070936 |
38 |
1.000
|
Human |
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
1.000
|
Human |
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
1.000
|
Human |
|
|
protein ubiquitination
|
GO:0016567 |
314 |
1.000
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
1.000
|
Human |
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
1.000
|
Human |
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
1.000
|
Human |
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
1.000
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
1.000
|
Human |
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
1.000
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.999
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.999
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.999
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.999
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.999
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.999
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
9 |
0.998
|
|
|
|
trail activated apoptotic signaling pathway
|
GO:0036462 |
4 |
0.998
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.997
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.997
|
Human |
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.997
|
|
|
|
protein autoubiquitination
|
GO:0051865 |
37 |
0.997
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.997
|
|
|
|
regulation of macrophage differentiation
|
GO:0045649 |
9 |
0.997
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
24 |
0.996
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.995
|
Human |
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.995
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.995
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.994
|
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
13 |
0.993
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.993
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.990
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.990
|
Human |
|
|
positive regulation of macrophage differentiation
|
GO:0045651 |
7 |
0.989
|
|
|
|
cellular modified amino acid catabolic process
|
GO:0042219 |
4 |
0.989
|
|
|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.988
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.987
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.985
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.985
|
|
|
|
g1 dna damage checkpoint
|
GO:0044783 |
18 |
0.983
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.981
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.977
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.976
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.974
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.974
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.973
|
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
13 |
0.968
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
39 |
0.967
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.966
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.966
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.964
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.964
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.961
|
|
|
|
positive regulation of cell cycle arrest
|
GO:0071158 |
23 |
0.956
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.954
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.954
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.954
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.953
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.953
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.952
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.951
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.950
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.946
|
Human Mouse Rat |
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.946
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.945
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.941
|
|
|
|
signal transduction involved in mitotic g1 dna damage checkpoint
|
GO:0072431 |
10 |
0.937
|
|
|
|
protein linear polyubiquitination
|
GO:0097039 |
5 |
0.936
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
37 |
0.935
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
70 |
0.931
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.929
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.928
|
Human |
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.926
|
|
|
|
mitotic g1 s transition checkpoint
|
GO:0044819 |
17 |
0.923
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.923
|
Human |
|
|
execution phase of apoptosis
|
GO:0097194 |
32 |
0.916
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.914
|
|
|
|
aortic valve development
|
GO:0003176 |
3 |
0.908
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.907
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.906
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.904
|
|
|
|
regulation of protein linear polyubiquitination
|
GO:1902528 |
2 |
0.904
|
|
|
|
protein monoubiquitination
|
GO:0006513 |
39 |
0.903
|
Human |
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.899
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.895
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.894
|
|
|
|
midbrain development
|
GO:0030901 |
45 |
0.893
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.893
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.889
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.888
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
17 |
0.887
|
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
53 |
0.886
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
8 |
0.880
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.880
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.876
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.870
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
10 |
0.868
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.860
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.860
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
39 |
0.860
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.860
|
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
16 |
0.858
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.839
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.838
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.838
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
2 |
0.831
|
|
|
|
positive regulation of cell fate specification
|
GO:0042660 |
2 |
0.821
|
|
|
|
cardiac vascular smooth muscle cell differentiation
|
GO:0060947 |
2 |
0.819
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.816
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.809
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.805
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.804
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.804
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.799
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.798
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.798
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.797
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.796
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.793
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.782
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.781
|
|
|
|
notch signaling involved in heart development
|
GO:0061314 |
2 |
0.779
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.779
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.778
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.769
|
|
|
|
positive regulation of protein monoubiquitination
|
GO:1902527 |
1 |
0.766
|
Human |
|
|
forebrain development
|
GO:0030900 |
26 |
0.760
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.759
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.759
|
|
|
|
regulation of protein polyubiquitination
|
GO:1902914 |
8 |
0.758
|
|
|
|
positive regulation of protein k48 linked ubiquitination
|
GO:1902524 |
1 |
0.756
|
Human |
|
|
cardiac right ventricle formation
|
GO:0003219 |
1 |
0.752
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.750
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.747
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.744
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.737
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.732
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.731
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.727
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.723
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.718
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.716
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.715
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.703
|
|
|
|
endocardial cushion development
|
GO:0003197 |
3 |
0.701
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.697
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.690
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.681
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.676
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.672
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003256 |
3 |
0.668
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.667
|
|
|
|
regulation of protein monoubiquitination
|
GO:1902525 |
1 |
0.666
|
Human |
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.655
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.653
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
26 |
0.651
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.633
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.625
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.624
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
65 |
0.622
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
35 |
0.621
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.621
|
|
|
|
negative regulation of humoral immune response
|
GO:0002921 |
7 |
0.617
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.616
|
|
|
|
regulation of necroptotic process
|
GO:0060544 |
7 |
0.614
|
Human |
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.609
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.603
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.599
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.587
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.578
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.573
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.568
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
14 |
0.558
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.553
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.549
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.544
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
2 |
0.539
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.535
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.525
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.522
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
15 |
0.520
|
|
|
|
regulation of mesodermal cell fate specification
|
GO:0042661 |
2 |
0.520
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
31 |
0.518
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.514
|
|
|
|
cellular response to uv
|
GO:0034644 |
32 |
0.512
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.511
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.509
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
33 |
0.507
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.499
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.498
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.496
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
13 |
0.490
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.484
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.479
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.471
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.469
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.467
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.464
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.461
|
|
|
|
distal tubule development
|
GO:0072017 |
4 |
0.458
|
|
|
|
neural nucleus development
|
GO:0048857 |
47 |
0.455
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
35 |
0.454
|
Rat |
|
|
response to cobalt ion
|
GO:0032025 |
1 |
0.451
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.448
|
|
|
|
negative regulation of i kappab kinase nf kappab signaling
|
GO:0043124 |
32 |
0.446
|
|
|
|
muscle cell fate commitment
|
GO:0042693 |
4 |
0.445
|
|
|
|
regulation of execution phase of apoptosis
|
GO:1900117 |
11 |
0.445
|
|
|
|
protein deubiquitination
|
GO:0016579 |
79 |
0.444
|
|
|
|
positive regulation of protein polyubiquitination
|
GO:1902916 |
3 |
0.438
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.437
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
42 |
0.433
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.433
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.427
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.424
|
|
|
|
negative regulation of endothelial cell chemotaxis
|
GO:2001027 |
4 |
0.417
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
4 |
0.414
|
|
|
|
system process
|
GO:0003008 |
349 |
0.412
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.411
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.410
|
|
|
|
cellular response to misfolded protein
|
GO:0071218 |
2 |
0.402
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.401
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.400
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.400
|
|
|
|
substantia nigra development
|
GO:0021762 |
45 |
0.394
|
|
|
|
head development
|
GO:0060322 |
108 |
0.394
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.393
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
15 |
0.391
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.391
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
15 |
0.388
|
Human |
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.385
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.372
|
|
|
|
histone ubiquitination
|
GO:0016574 |
31 |
0.372
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.372
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.370
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.369
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.367
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.362
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.361
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.360
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061419 |
2 |
0.353
|
|
|
|
protein k63 linked ubiquitination
|
GO:0070534 |
31 |
0.352
|
Human |
|
|
neuron death
|
GO:0070997 |
65 |
0.349
|
Mouse Rat |
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.348
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
21 |
0.348
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.343
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.340
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.340
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.337
|
|
|
|
mitral valve development
|
GO:0003174 |
3 |
0.334
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.330
|
Mouse Rat |
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
3 |
0.327
|
|
|
|
activation of innate immune response
|
GO:0002218 |
55 |
0.326
|
|
|
|
natural killer cell apoptotic process
|
GO:0070246 |
1 |
0.325
|
Human |
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.319
|
|
|
|
apoptotic nuclear changes
|
GO:0030262 |
13 |
0.318
|
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
29 |
0.317
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.309
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.304
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.298
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
3 |
0.298
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.294
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.294
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.293
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.289
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.289
|
|
|
|
cell fate commitment involved in pattern specification
|
GO:0060581 |
1 |
0.287
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.286
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
30 |
0.286
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.277
|
|
|
|
cellular component disassembly involved in execution phase of apoptosis
|
GO:0006921 |
13 |
0.276
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.274
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.269
|
|
|
|
cellular response to toxic substance
|
GO:0097237 |
4 |
0.269
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.264
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.263
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.257
|
|
|
|
humoral immune response
|
GO:0006959 |
49 |
0.252
|
|
|
|
response to alkaloid
|
GO:0043279 |
20 |
0.250
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
1 |
0.249
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.249
|
|
|
|
vascular smooth muscle cell development
|
GO:0097084 |
1 |
0.248
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.244
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
2 |
0.244
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.243
|
|
|
|
cellular response to xenobiotic stimulus
|
GO:0071466 |
29 |
0.243
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.242
|
|
|
|
secondary metabolic process
|
GO:0019748 |
17 |
0.241
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.241
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
2 |
0.237
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
54 |
0.237
|
|
|
|
atrial septum morphogenesis
|
GO:0060413 |
5 |
0.235
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.235
|
|
|
|
regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031664 |
13 |
0.234
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
3 |
0.231
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.230
|
|
|
|
negative regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000059 |
3 |
0.229
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.223
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.222
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.221
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.218
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
7 |
0.210
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.206
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
1 |
0.203
|
|
|
|
dna catabolic process
|
GO:0006308 |
49 |
0.198
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.194
|
|
|
|
i kappab phosphorylation
|
GO:0007252 |
7 |
0.193
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.192
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.192
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
1 |
0.192
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
71 |
0.190
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.186
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.186
|
|
|
|
response to antibiotic
|
GO:0046677 |
15 |
0.182
|
|
|
|
cellular response to corticosteroid stimulus
|
GO:0071384 |
5 |
0.181
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.179
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.178
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.177
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.173
|
|
|
|
er associated ubiquitin dependent protein catabolic process
|
GO:0030433 |
31 |
0.171
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
2 |
0.170
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.167
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
31 |
0.164
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.163
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
61 |
0.162
|
|
|
|
response to retinoic acid
|
GO:0032526 |
33 |
0.161
|
|
|
|
hippocampus development
|
GO:0021766 |
1 |
0.159
|
|
|
|
alpha amino acid catabolic process
|
GO:1901606 |
26 |
0.154
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.151
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.150
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.150
|
|
|
|
hair cell differentiation
|
GO:0035315 |
2 |
0.150
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
2 |
0.150
|
|
|
|
cardiac muscle cell myoblast differentiation
|
GO:0060379 |
5 |
0.149
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.149
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
37 |
0.149
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.146
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.144
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
24 |
0.140
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.140
|
|
|
|
immunoglobulin secretion
|
GO:0048305 |
1 |
0.138
|
|
|
|
macrophage differentiation
|
GO:0030225 |
11 |
0.138
|
|
|
|
regulation of interleukin 2 secretion
|
GO:1900040 |
2 |
0.138
|
|
|
|
cellular response to dexamethasone stimulus
|
GO:0071549 |
1 |
0.138
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.138
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.137
|
|
|
|
cytokine secretion
|
GO:0050663 |
64 |
0.135
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
92 |
0.133
|
|
|
|
viral release from host cell
|
GO:0019076 |
21 |
0.133
|
|
|
|
neural tube development
|
GO:0021915 |
9 |
0.132
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
34 |
0.130
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
42 |
0.128
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.128
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.127
|
|
|
|
regulation of endothelial cell differentiation
|
GO:0045601 |
4 |
0.125
|
|
|
|
regulation of gastrulation
|
GO:0010470 |
12 |
0.124
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.123
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.122
|
|
|
|
renal system process
|
GO:0003014 |
25 |
0.121
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
3 |
0.120
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.120
|
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
61 |
0.120
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.119
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
33 |
0.119
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.118
|
|
|
|
long term memory
|
GO:0007616 |
2 |
0.118
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
2 |
0.118
|
|
|
|
lipid homeostasis
|
GO:0055088 |
39 |
0.115
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
6 |
0.115
|
|
|
|
positive regulation of cardiac muscle cell proliferation
|
GO:0060045 |
2 |
0.114
|
|
|
|
regulation of neuron death
|
GO:1901214 |
56 |
0.114
|
Rat |
|
|
necroptotic process
|
GO:0070266 |
16 |
0.114
|
Human |
|
|
activation of mapk activity
|
GO:0000187 |
45 |
0.113
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.113
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.112
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.111
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
40 |
0.111
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.111
|
|
|
|
interaction with host
|
GO:0051701 |
42 |
0.110
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.110
|
|
|
|
positive regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031666 |
4 |
0.109
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
2 |
0.109
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.108
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
1 |
0.108
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.108
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.107
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.106
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
2 |
0.106
|
|
|
|
heart formation
|
GO:0060914 |
2 |
0.105
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.105
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.105
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.105
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.105
|
|
|
|
b cell homeostasis
|
GO:0001782 |
1 |
0.104
|
|
|
|
response to ketone
|
GO:1901654 |
19 |
0.103
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.103
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.102
|
|
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
25 |
0.102
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.102
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.101
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.100
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.099
|
|
|
|
endocardium development
|
GO:0003157 |
2 |
0.099
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
7 |
0.099
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.097
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.096
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
29 |
0.096
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
2 |
0.096
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
36 |
0.096
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.096
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.096
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
3 |
0.095
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.094
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.093
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.092
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
31 |
0.091
|
Human |
|
|
t cell proliferation
|
GO:0042098 |
45 |
0.089
|
|
|
|
protein stabilization
|
GO:0050821 |
64 |
0.089
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.088
|
|
|
|
spermatogenesis
|
GO:0007283 |
22 |
0.088
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
60 |
0.087
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
2 |
0.087
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.087
|
|
|
|
negative regulation of myotube differentiation
|
GO:0010832 |
4 |
0.087
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
52 |
0.087
|
|
|
|
negative regulation of pro b cell differentiation
|
GO:2000974 |
1 |
0.086
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.086
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.086
|
|
|
|
regulation of viral release from host cell
|
GO:1902186 |
20 |
0.086
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.085
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.085
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.084
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.084
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.082
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.081
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
2 |
0.081
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.081
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
4 |
0.080
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.080
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
92 |
0.079
|
|
|
|
viral gene expression
|
GO:0019080 |
35 |
0.079
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.077
|
|
|
|
sensory perception of sound
|
GO:0007605 |
37 |
0.077
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.076
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
35 |
0.076
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.076
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
101 |
0.075
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.075
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.075
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.075
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.074
|
|
|
|
response to corticosteroid
|
GO:0031960 |
15 |
0.074
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.074
|
|
|
|
response to topologically incorrect protein
|
GO:0035966 |
29 |
0.074
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
22 |
0.073
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.073
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
13 |
0.073
|
|
|
|
positive regulation of protein linear polyubiquitination
|
GO:1902530 |
2 |
0.072
|
|
|
|
venous blood vessel development
|
GO:0060841 |
2 |
0.072
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.071
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
26 |
0.071
|
|
|
|
regulation of apoptotic dna fragmentation
|
GO:1902510 |
3 |
0.071
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.070
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.069
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.069
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.069
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.068
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.068
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
33 |
0.068
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
2 |
0.068
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.067
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.067
|
|
|
|
cardioblast cell fate commitment
|
GO:0042684 |
1 |
0.067
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.067
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.066
|
|
|
|
androgen receptor signaling pathway
|
GO:0030521 |
34 |
0.065
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.065
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.065
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.064
|
|
|
|
myoblast proliferation
|
GO:0051450 |
1 |
0.064
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.064
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
80 |
0.063
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.062
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
1 |
0.062
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.062
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.061
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.061
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
54 |
0.061
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.061
|
|
|
|
negative regulation of viral entry into host cell
|
GO:0046597 |
12 |
0.061
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
19 |
0.061
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.060
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
9 |
0.060
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.060
|
|